Health TrialsbyHealthPanel

Follow-up Study for Participants of Jointstem Investigator Initiated Trial by Arthroscopy

ConditionsDegenerative ArthritisKnee Arthritis
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20+
SponsorR-Bio

About this trial

This clinical trial is conducted to assess the long-term safety of "jointstem" in patients with degenerative knee arthritis who participated in the previous BS-JS-IIT1 investigator initiated trial.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Participants of Jointstem IIT by arthroscopy (BS-JS-IIT1)

Participants who signed informed consent document of this study

Disqualifiers

No applicable

Trial design

Design model

Single group

Treatments tested in this trial

  • JOINTSTEM

    Drug

    JOINTSTEM is an OA treatment that uses autologous adipose-derived mesenchymal stem cells. As it does not use allogenic tissues and is incubated without additional genetic modification or mechanical and chemical modification through differentiation, it is classified as 'autologous cell therapy' and is completely free of immunologic rejection.

Treatment groups

14 Participants
are divided into 1 treatment group
Group A: Long Term Follow-up after Jointstem TransplantationExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Adverse Events

Incidence of adverse events from baseline to 60 months

Time frame
60 Month

Secondary outcomes

1

Adverse Events (Special Attention Target)

Incidence of adverse events(special attention target: malicious tumor, autoimmune disease) from baseline to 60 months

Time frame
60 months

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

R-Bio

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: